Understanding COVID-19 Data

Diagnoses of the six most prevalent cancers have decreased sharply, according to recent reports—indicative of big changes to oncology during the pandemic. On this mini-podcast, we look at the latest data on the effects of COVID-19 on cancer practices and explore how you can adapt to changes in oncology business. Guest: Jennifer Webster, MS, Vice President of Analytics and Data Solutions, Integra Connect Related Content:  ACCC COVID-19 Resource Center Webcast: Risk Stratification for Cancer Patients During COVID-19 Mini-Podcast: COVID-19 & Telemedicine Mini-Podcast: Cancer Screening During COVID-19 The "New Normal": Seven Questions Program Leaders Are Asking About Care Amid COVID-19 This mini-podcast is supported by educational grants from AstraZeneca Pharmaceuticals, Merck & Co., Inc., and Pfizer Inc. The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.